Marcj you seem to know something about Roche pharmacuticals and their new trial. Do you have answers to these questions?
1 How far away is this from market 2 Are there any known side effects to the treatment 3 Do they have pricing arranged 4 Is Hep C the only disease it targets 5 What percentage of people is it effective in treating.
I suffer from mild asthma and the amount of times over the years I've heard about trials of a new product to cure it is amazing. I'm still waiting for a cure! SLA are at the brink of releasing Ropren which is a company making product. Ropren helps the immune system fight of a number of diseases including liver disease so even though Roche pharmacutical's might have a new product for Hep C (which could be years away) it wont have a huge impact if any on Ropren sales.
SLA Price at posting:
23.0¢ Sentiment: LT Buy Disclosure: Held